FDA issues new guidance on x-rays for children

Imaging professionals are urged to “child size,” or use the lowest radiation dose needed, in medical imaging exams on pediatric patients, according to new guidance issued on x-rays by the US Food & Drug Administration (FDA).

Though the pediatric population is defined by the FDA as birth to 21 years old, the announcement said a patient’s size, rather than their age, is a determinant for dosage.

“While the level of risk from the radiation associated with x-rays is small, especially when compared with the benefits of an accurate diagnosis, health care professionals must be especially sensitive to their appropriate use in children,” said the FDA in the statement. “Pediatric patients generally require less radiation than adults to obtain a quality image from an x-ray exam, so doctors must take extra care to ‘child size’ the radiation dose.”

Healthcare professionals are urged to ensure justification of pediatric x-ray imaging. Additionally, the FDA recommends healthcare professionals explore imaging modalities that do not expose the patient to ionizing radiation, which can obtain the same result.

""

As a senior news writer for TriMed, Subrata covers cardiology, clinical innovation and healthcare business. She has a master’s degree in communication management and 12 years of experience in journalism and public relations.

Around the web

The ACR hopes these changes, including the addition of diagnostic performance feedback, will help reduce the number of patients with incidental nodules lost to follow-up each year.

And it can do so with almost 100% accuracy as a first reader, according to a new large-scale analysis.

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.